Add Company
Join Now

Sherri Van Email

VP, Ophthalmology Clinical Development . REGENXBIO

Rockville, MD

Location

How to contact Sherri Van

Join and see Sherri's contact info for free!

Email

Current Roles

REGENXBIO

Employees:
410
Revenue:
$93.1M
About
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and thirdparty NAV Technology Platform licensees.
REGENXBIO Address
9804 Medical Center Drive
Rockville, MD
United States
REGENXBIO Email

Past Companies

REGENXBIO Inc.Vice President, Ophthalmology Clinical Development
REGENXBIO Inc.Vice President Medical Affairs
Jack McGovern Coats Disease FoundationMember Board of Directors
www.growjo.com

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.